Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty

Abstract Background Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss wi...

Full description

Bibliographic Details
Main Authors: Yong Hu, Min-Cong Wang, Tao Wang, Yue Meng, Xiao-Min Chao, Hui-Feng Zhu, Cheng-Guo Li, Cheng-Long Pan, He-Bei He
Format: Article
Language:English
Published: BMC 2021-03-01
Series:Journal of Orthopaedic Surgery and Research
Subjects:
Online Access:https://doi.org/10.1186/s13018-021-02363-z
_version_ 1817997201433952256
author Yong Hu
Min-Cong Wang
Tao Wang
Yue Meng
Xiao-Min Chao
Hui-Feng Zhu
Cheng-Guo Li
Cheng-Long Pan
He-Bei He
author_facet Yong Hu
Min-Cong Wang
Tao Wang
Yue Meng
Xiao-Min Chao
Hui-Feng Zhu
Cheng-Guo Li
Cheng-Long Pan
He-Bei He
author_sort Yong Hu
collection DOAJ
description Abstract Background Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conventional posterolateral total hip arthroplasty (PLTH). Methods This retrospective study enrolled patients who underwent unilateral primary THA between January 2017 and December 2019. The demographic data, diagnoses, affected side, radiographic findings, hemoglobin concentration, hematocrit, operative time, transfusion requirements, and intra-operative blood loss were recorded. The peri-operative blood loss was calculated using the OSTHEO formula. Blood loss on the 1st, 3rd, and 5th post-operative days was calculated. Hidden blood loss (HBL) was determined by subtracting the intra-operative blood loss from the total blood loss. Results Two hundred sixty-three patients were included in the study, 85 of whom were in the SuperPath group and 178 in the posterolateral total hip arthroplasty (PLTH) group. Patient demographics, diagnoses, affected side, operative times, and pre-operative hemoglobin concentrations did not differ significantly between the two groups (all P > 0.05). Compared to the PLTH group, the SuperPath group had less blood loss, including intra-operative blood loss, 1st, 3rd, and 5th post-operative days blood loss, and HBL (all P < 0.05). Total blood loss and HBL was 790.07 ± 233.37 and 560.67 ± 195.54 mL for the SuperPath group, respectively, and 1141.26 ± 482.52 and 783.45 ± 379.24 mL for the PLTH group. PLTH led to a greater reduction in the post-operative hematocrit than SuperPath (P < 0.001). A much lower transfusion rate (P = 0.028) and transfusion volume (P = 0.019) was also noted in the SuperPath group. Conclusion SuperPath resulted in less perioperative blood loss and a lower transfusion rate than conventional PLTH.
first_indexed 2024-04-14T02:34:49Z
format Article
id doaj.art-c59f8577f443442b9b1edf27012276e8
institution Directory Open Access Journal
issn 1749-799X
language English
last_indexed 2024-04-14T02:34:49Z
publishDate 2021-03-01
publisher BMC
record_format Article
series Journal of Orthopaedic Surgery and Research
spelling doaj.art-c59f8577f443442b9b1edf27012276e82022-12-22T02:17:34ZengBMCJournal of Orthopaedic Surgery and Research1749-799X2021-03-011611910.1186/s13018-021-02363-zLess blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplastyYong Hu0Min-Cong Wang1Tao Wang2Yue Meng3Xiao-Min Chao4Hui-Feng Zhu5Cheng-Guo Li6Cheng-Long Pan7He-Bei He8Present Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Orthopaedic Surgery, The Third Affiliated Hospital of GuangZhou Medical CollegePresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityPresent Address: Department of Joint Surgery, The Fifth Affiliated Hospital of Southern Medical UniversityAbstract Background Although excellent clinical outcomes of supercapsular percutaneously assisted total hip arthroplasty (SuperPath) have been reported, the peri-operative blood loss has rarely been reported. The current study determined the blood loss during SuperPath and compared the blood loss with conventional posterolateral total hip arthroplasty (PLTH). Methods This retrospective study enrolled patients who underwent unilateral primary THA between January 2017 and December 2019. The demographic data, diagnoses, affected side, radiographic findings, hemoglobin concentration, hematocrit, operative time, transfusion requirements, and intra-operative blood loss were recorded. The peri-operative blood loss was calculated using the OSTHEO formula. Blood loss on the 1st, 3rd, and 5th post-operative days was calculated. Hidden blood loss (HBL) was determined by subtracting the intra-operative blood loss from the total blood loss. Results Two hundred sixty-three patients were included in the study, 85 of whom were in the SuperPath group and 178 in the posterolateral total hip arthroplasty (PLTH) group. Patient demographics, diagnoses, affected side, operative times, and pre-operative hemoglobin concentrations did not differ significantly between the two groups (all P > 0.05). Compared to the PLTH group, the SuperPath group had less blood loss, including intra-operative blood loss, 1st, 3rd, and 5th post-operative days blood loss, and HBL (all P < 0.05). Total blood loss and HBL was 790.07 ± 233.37 and 560.67 ± 195.54 mL for the SuperPath group, respectively, and 1141.26 ± 482.52 and 783.45 ± 379.24 mL for the PLTH group. PLTH led to a greater reduction in the post-operative hematocrit than SuperPath (P < 0.001). A much lower transfusion rate (P = 0.028) and transfusion volume (P = 0.019) was also noted in the SuperPath group. Conclusion SuperPath resulted in less perioperative blood loss and a lower transfusion rate than conventional PLTH.https://doi.org/10.1186/s13018-021-02363-zTotal hip arthroplastySupercapsular percutaneously assistedMinimally invasiveBlood lossTransfusion
spellingShingle Yong Hu
Min-Cong Wang
Tao Wang
Yue Meng
Xiao-Min Chao
Hui-Feng Zhu
Cheng-Guo Li
Cheng-Long Pan
He-Bei He
Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
Journal of Orthopaedic Surgery and Research
Total hip arthroplasty
Supercapsular percutaneously assisted
Minimally invasive
Blood loss
Transfusion
title Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
title_full Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
title_fullStr Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
title_full_unstemmed Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
title_short Less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
title_sort less blood loss in supercapsular percutaneously assisted versus posterolateral total hip arthroplasty
topic Total hip arthroplasty
Supercapsular percutaneously assisted
Minimally invasive
Blood loss
Transfusion
url https://doi.org/10.1186/s13018-021-02363-z
work_keys_str_mv AT yonghu lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT mincongwang lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT taowang lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT yuemeng lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT xiaominchao lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT huifengzhu lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT chengguoli lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT chenglongpan lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty
AT hebeihe lessbloodlossinsupercapsularpercutaneouslyassistedversusposterolateraltotalhiparthroplasty